je.st
news
Tag: pfizer
Pfizer Inc. (PFE) Raised to Buy at Zacks Investment Research
2016-02-01 05:58:39| Biotech - Topix.net
The firm currently has a $34.00 price target on the biopharmaceutical company's stock. Zacks Investment Research 's target price suggests a potential upside of 11.51% from the company's previous close.
Tags: buy
research
investment
raised
Pfizer Inc. (PFE) Sees Large Increase in Short Interest
2016-01-17 11:36:07| Biotech - Topix.net
Pfizer Inc. saw a large growth in short interest in the month of December. As of December 31st, there was short interest totalling 123,454,015 shares, a growth of 44.1% from the December 15th total of 85,657,779 shares, MarketBeat Ratings reports.
Tags: large
short
interest
increase
Caledonia Investments Has $11,137,000 Position in Pfizer Inc.
2016-01-14 10:52:37| Trucking - Topix.net
Caledonia Investments held its stake in shares of Pfizer Inc. during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 345,000 shares of the biopharmaceutical company's stock at the end of the fourth quarter.
Tags: inc
position
investments
caledonia
Pfizer, Allergan CEOs: Tie-up aims to produce more meds, sales, isn't focused on cutting costs
2016-01-12 23:12:49| Biotech - Topix.net
The heads of drugmakers Pfizer and Allergan said Tuesday that the record $160 billion combination they're planning is meant to produce more medicines and boost revenue, not to just slash jobs and other costs as the companies previously have done. The deal announced last November would move Pfizer's official headquarters for tax purposes from New York to Allergan's base in Ireland.
Tags: sales
costs
produce
focused
Pfizer Hikes Prices for Over 100 Drugs on January 1
2016-01-09 08:17:58| Biotech - Topix.net
Pfizer Inc, which plans a $160-billion merger with Ireland-based Allergan Plc to slash its U.S. tax bill, on Jan. 1 raised U.S. prices for more than 100 of its drugs, some by as much as 20 percent, according to statistics compiled by global information services company Wolters Kluwer. Pfizer confirmed a 9.4 percent increase for heavily advertised pain drug Lyrica, which generated $2.3 billion in 2014 U.S. sales; a 12.9 percent increase for erectile dysfunction drug Viagra, which had 2014 U.S. sales of $1.1 billion; and a 5 percent increase for Ibrance, a novel breast cancer drug launched last year at a list price of $9,850 per month, or $118,200 per year.
Tags: january
prices
drugs
pfizer
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] next »